Steve Schonfeld’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Steve Schonfeld's NRIX Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Nurix Therapeutics (NRIX) in Q3 2026: 118,227 shares worth $2.8M. The stake represents 0.01% of the portfolio and ranks #959 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in NRIX as recently as Q2 2025.
Steve Schonfeld first reported a position in NRIX in Q4 2021 and has held it in 8 quarters since. The position peaked at $9.02M in Q2 2024. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Steve Schonfeld held 118,227 shares of Nurix Therapeutics worth $2.8M as of Q3 2026.
- Nurix Therapeutics was a new Steve Schonfeld position in Q3 2026.
- Nurix Therapeutics made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #959 holding.
- Steve Schonfeld first reported a position in Nurix Therapeutics in Q4 2021 and has held it in 8 quarters since.
- Steve Schonfeld's Nurix Therapeutics position peaked at $9.02M in Q2 2024.
- 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.